Aclarion 

$3.57
74
+$0.29+9.02% Today

Statistics

Day High
3.57
Day Low
3.2
52W High
13.69
52W Low
2.34
Volume
36,226
Avg. Volume
862,011
Mkt Cap
2.39M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

3JunExpected
Q2 2024
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-452.25
-301.55
-150.85
-0.15
Expected EPS
-1.55
Actual EPS
N/A

Financials

-15,202.17%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
92,000Revenue
-13.99MNet Income

Analyst Ratings

$7.00Average Price Target
The highest estimate is 7.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ACON. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
GE Aerospace
GE
Mkt Cap325.88B
General Electric, through its healthcare division, offers medical imaging, biomanufacturing, and cell therapy technologies, competing in the broader medical technology space with Aclarion.
Siemens
SIEGY
Mkt Cap224.45B
Siemens Healthineers offers a wide range of medical imaging and diagnostic technologies, directly competing with Aclarion's focus on medical imaging solutions.
Koninklijke Philips N.V.
PHG
Mkt Cap26.17B
Philips is a diversified technology company that offers diagnostic imaging, patient monitoring, and health informatics, competing in the same healthcare technology space as Aclarion.
Thermo Fisher Scientific
TMO
Mkt Cap214.25B
Thermo Fisher Scientific provides analytical instruments, lab equipment, and specialty diagnostics, competing in the medical diagnostics and research tools sector alongside Aclarion.
Danaher
DHR
Mkt Cap152.13B
Danaher Corporation operates in the life sciences, diagnostics, and environmental industries, offering products and services that compete with Aclarion's medical technology offerings.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific Corporation specializes in medical devices used in interventional medical specialties, competing with Aclarion in the medical devices and technology market.
Medtronic
MDT
Mkt Cap116.33B
Medtronic plc offers medical technologies, services, and solutions, including imaging and neurological products, directly competing with Aclarion in the medical technology and devices sector.
Intuitive Surgical
ISRG
Mkt Cap189.4B
Intuitive Surgical, Inc. specializes in robotic-assisted, minimally invasive surgery, competing with Aclarion in the innovative medical technology and equipment sector.
Abbott Laboratories
ABT
Mkt Cap214.96B
Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products, including diagnostic solutions that compete with Aclarion.
Stryker
SYK
Mkt Cap136.19B
Stryker Corporation specializes in medical technologies, including surgical, neurotechnology, and spine products, competing with Aclarion in the medical technology and equipment market.

About

Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.
Show more...
CEO
Dr. Jeffrey John Thramann M.D.
Employees
5
Country
US
ISIN
US6551874091

Listings

0 Comments

Share your thoughts

FAQ

What is Aclarion stock price today?
The current price of ACON is $3.57 USD — it has increased by +9.02% in the past 24 hours. Watch Aclarion stock price performance more closely on the chart.
What is Aclarion stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Aclarion stocks are traded under the ticker ACON.
Is Aclarion stock price growing?
ACON stock has risen by +6.5% compared to the previous week, the month change is a +25.55% rise, over the last year Aclarion has showed a -69.58% decrease.
What is Aclarion market cap?
Today Aclarion has the market capitalization of 2.39M
When is the next Aclarion earnings date?
Aclarion is going to release the next earnings report on June 03, 2026.
What were Aclarion earnings last quarter?
ACON earnings for the last quarter are -2.56 USD per share, whereas the estimation was -3.6 USD resulting in a +28.89% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Aclarion revenue for the last year?
Aclarion revenue for the last year amounts to 92,000 USD.
What is Aclarion net income for the last year?
ACON net income for the last year is -13.99M USD.
How many employees does Aclarion have?
As of April 01, 2026, the company has 5 employees.
In which sector is Aclarion located?
Aclarion operates in the Health Care sector.
When did Aclarion complete a stock split?
The last stock split for Aclarion was on January 30, 2025 with a ratio of 1:335.
Where is Aclarion headquartered?
Aclarion is headquartered in Broomfield, US.